| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1005 | 24 | 1252 | 90 | 1096 | 194 | 1181 |
| ERLYTX | 89 | 0 | 0 | 3 | 37 | 8 | 49 |
| GI | 189 | 2 | 104 | 12 | 146 | 25 | 152 |
| GU | 437 | 8 | 417 | 28 | 341 | 64 | 390 |
| LEUK | 141 | 1 | 52 | 12 | 146 | 21 | 128 |
| LUNG | 169 | 4 | 209 | 20 | 244 | 39 | 237 |
| LYMPH | 398 | 7 | 365 | 32 | 390 | 59 | 359 |
| MELAN | 276 | 0 | 0 | 1 | 12 | 2 | 12 |
| MMYEL | 151 | 1 | 52 | 6 | 73 | 11 | 67 |
| MULT | 22 | 0 | 0 | 7 | 85 | 12 | 73 |
| OTHER | 40 | 0 | 0 | 3 | 37 | 8 | 49 |
| PREV | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2921 | 47 | 2451 | 214 | 2607 | 443 | 2697 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 115 | 0 | 0 | 13 | 158 | 29 | 177 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 667 | 10 | 522 | 51 | 621 | 103 | 627 |
| LUNG | 312 | 5 | 261 | 31 | 377 | 64 | 390 |
| OTHER | 36 | 1 | 52 | 4 | 49 | 10 | 61 |
| PEOLC | 131 | 3 | 157 | 15 | 183 | 32 | 195 |
| PREV | 204 | 2 | 104 | 24 | 292 | 44 | 268 |
| SURV | 19 | 0 | 0 | 2 | 24 | 4 | 24 |
| SXQOL | 562 | 3 | 157 | 44 | 536 | 97 | 590 |
| Total | 2056 | 24 | 1253 | 184 | 2240 | 384 | 2338 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1005 | 24 | 1252 | 90 | 1096 | 194 | 1181 |
| CCD | 115 | 0 | 0 | 13 | 158 | 29 | 177 |
| ERLYTX | 99 | 0 | 0 | 3 | 37 | 9 | 55 |
| GI | 189 | 2 | 104 | 12 | 146 | 25 | 152 |
| GU | 437 | 8 | 417 | 28 | 341 | 64 | 390 |
| LEUK | 808 | 11 | 574 | 63 | 767 | 124 | 755 |
| LUNG | 481 | 9 | 470 | 51 | 621 | 103 | 627 |
| LYMPH | 398 | 7 | 365 | 32 | 390 | 59 | 359 |
| MELAN | 276 | 0 | 0 | 1 | 12 | 2 | 12 |
| MMYEL | 151 | 1 | 52 | 6 | 73 | 11 | 67 |
| MULT | 22 | 0 | 0 | 7 | 85 | 12 | 73 |
| OTHER | 76 | 1 | 52 | 7 | 85 | 18 | 110 |
| PEOLC | 131 | 3 | 157 | 15 | 183 | 32 | 195 |
| PREV | 206 | 2 | 104 | 24 | 292 | 44 | 268 |
| SURV | 19 | 0 | 0 | 2 | 24 | 4 | 24 |
| SXQOL | 564 | 3 | 157 | 44 | 536 | 97 | 590 |
| Total | 4977 | 71 | 3704 | 398 | 4846 | 827 | 5035 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 620 | 15 | 783 | 55 | 670 | 121 | 737 |
| ERLYTX | 48 | 0 | 0 | 2 | 24 | 4 | 24 |
| GI | 136 | 1 | 52 | 9 | 110 | 20 | 122 |
| GU | 366 | 7 | 365 | 23 | 280 | 49 | 298 |
| LEUK | 88 | 1 | 52 | 10 | 122 | 15 | 91 |
| LUNG | 105 | 2 | 104 | 8 | 97 | 17 | 103 |
| LYMPH | 256 | 3 | 157 | 22 | 268 | 38 | 231 |
| MELAN | 174 | 0 | 0 | 1 | 12 | 2 | 12 |
| MMYEL | 99 | 0 | 0 | 4 | 49 | 7 | 43 |
| MULT | 8 | 0 | 0 | 2 | 24 | 4 | 24 |
| OTHER | 40 | 0 | 0 | 3 | 37 | 8 | 49 |
| PREV | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1944 | 29 | 1513 | 139 | 1693 | 285 | 1734 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 103 | 0 | 0 | 12 | 146 | 26 | 158 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 300 | 3 | 157 | 17 | 207 | 47 | 286 |
| LUNG | 193 | 5 | 261 | 21 | 256 | 42 | 256 |
| OTHER | 35 | 0 | 0 | 3 | 37 | 9 | 55 |
| PEOLC | 93 | 2 | 104 | 12 | 146 | 25 | 152 |
| PREV | 204 | 2 | 104 | 24 | 292 | 44 | 268 |
| SURV | 19 | 0 | 0 | 2 | 24 | 4 | 24 |
| SXQOL | 379 | 3 | 157 | 31 | 377 | 60 | 365 |
| Total | 1336 | 15 | 783 | 122 | 1485 | 258 | 1570 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 800 | 17 | 887 | 60 | 731 | 150 | 913 |
| CCD | 134 | 0 | 0 | 11 | 134 | 27 | 164 |
| ERLYTX | 58 | 0 | 0 | 2 | 24 | 5 | 30 |
| GI | 141 | 1 | 52 | 8 | 97 | 20 | 122 |
| GU | 382 | 6 | 313 | 26 | 317 | 55 | 335 |
| LEUK | 388 | 4 | 209 | 27 | 329 | 62 | 377 |
| LUNG | 299 | 7 | 365 | 29 | 353 | 59 | 359 |
| LYMPH | 256 | 3 | 157 | 22 | 268 | 38 | 231 |
| MELAN | 174 | 0 | 0 | 1 | 12 | 2 | 12 |
| MMYEL | 96 | 0 | 0 | 4 | 49 | 7 | 43 |
| MULT | 24 | 1 | 52 | 3 | 37 | 8 | 49 |
| OTHER | 256 | 1 | 52 | 19 | 231 | 41 | 250 |
| PEOLC | 97 | 2 | 104 | 11 | 134 | 25 | 152 |
| PREV | 206 | 2 | 104 | 24 | 292 | 44 | 268 |
| SURV | 19 | 0 | 0 | 2 | 24 | 4 | 24 |
| SXQOL | 381 | 3 | 157 | 31 | 377 | 60 | 365 |
| Total | 3711 | 47 | 2452 | 280 | 3409 | 607 | 3694 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 848 | 19 | 991 | 68 | 828 | 152 | 925 |
| ERLYTX | 85 | 0 | 0 | 3 | 37 | 8 | 49 |
| GI | 108 | 2 | 104 | 7 | 85 | 14 | 85 |
| GU | 254 | 8 | 417 | 22 | 268 | 45 | 274 |
| LEUK | 109 | 1 | 52 | 6 | 73 | 14 | 85 |
| LUNG | 135 | 2 | 104 | 16 | 195 | 33 | 201 |
| LYMPH | 323 | 5 | 261 | 24 | 292 | 47 | 286 |
| MMYEL | 140 | 1 | 52 | 6 | 73 | 10 | 61 |
| MULT | 22 | 0 | 0 | 7 | 85 | 12 | 73 |
| Total | 2024 | 38 | 1981 | 159 | 1936 | 335 | 2039 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1929 | 26 | 1357 | 162 | 1972 | 333 | 2027 |
| AFFIL | 121 | 3 | 157 | 17 | 207 | 29 | 177 |
| CCOP/NCORP | 1230 | 15 | 783 | 82 | 998 | 181 | 1102 |
| Non-SWOG | 1692 | 22 | 1148 | 132 | 1607 | 279 | 1698 |
| Total | 4972 | 66 | 3445 | 393 | 4784 | 822 | 5004 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| GU | A031801 | GU, mRCC, Cabozantinib ± Radium-223 | 1 | E | 19-DEC-25 |
| LUNG | S1827 | SCLC, MRI Surveillance +/- PCI | 1 | N | 15-DEC-25 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 16 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 10 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 7 |
| GU | S1802 | Pros, Stg IV, SST ± Surg/RT to Primary Tum | 1 | 6 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 6 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 5 |
| BREAST | A012301 | Breast, Early Stg, Tamoxifen | 1 | 4 |
| OTHER | 10323 | Moonshot Biobank Research | 1 | 3 |
| LYMPH | S2114 | NHL, Rel/Ref, CD19 CAR-T +/- Consolidation | 1 | 3 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 3 |
| PEOLC | S2408 | Panc Fistula Prevention, Lanreotide | 1 | 3 |